Andreas Struengmann & family

$10.66B
$65.8M (0.6%)
as of 11/07/24

About Andreas Struengmann & family

Andreas Struengmann and twin brother Thomas were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.

The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.

The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.

In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.

Personal stats

Citizenship

Germany

Source of wealth

Pharmaceuticals

Residence

Tegernsee, Germany

Marital status

Married

Birth date

02/16/50 (age 74)

Number of children

2

Education

Medical Doctor, University at Buffalo

Self-made

self-made

Andreas Struengmann & family’s fortune is worth

178K

troy ounces of gold

164K

median U.S. household

107K

median U.S. income

0.213%

U.S. credit card volume

0.043%

GDP of the United States

0.031%

United States debt

Net worth history

Annual ranking

Did you know?

After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa.

Net worth over time

Real-time ranking

Financial assets

NASDAQ | BNTX-US

BioNTech Sponsored ADR

undefined | undefined

Formycon

Images © Forbes.com. All rights reserved.